Muhyiddin among first to be vaccinated against Covid-19
Modified22 Dec 2020, 3:12 am
A
-
COVID-19 | Prime Minister Muhyiddin Yassin will be among the first individuals to receive the Covid-19 vaccine in a bid to convince the people that the vaccine obtained by the country is safe and effective.
He said it would be followed by the frontliners, before being given to target groups, namely high-risk groups such as the elderly, those with non-communicable diseases and chronic respiratory diseases.
He said the Special Vaccine Supply Access Guarantee Committee, which had been established and co-chaired by the health minister and the.
All Access Plan
22 Dec 2020 / 11:19 H.
KUALA LUMPUR: Tan Sri Muhyiddin Yassin (
pix) will be among the first individuals to receive the Covid-19 vaccine in a bid to convince the people that the vaccine obtained by the country is safe and effective.
The Prime Minister said it would be followed by the frontliners, before being given to target groups, namely high-risk groups such as the elderly, those with non-communicable diseases and chronic respiratory diseases.
He said the Special Vaccine Supply Access Guarantee Committee, which had been established and co-chaired by the Minister of Health and the Minister of Science, Technology and Innovation would ensure that the supply of vaccines could be obtained immediately.
The government will ensure Covid-19 vaccines procured are safe and effective, he said.
Muhyiddin said this in a short video on the latest development regarding the distribution of the Covid-19 vaccine to Malaysians.
He said the Special Vaccine Supply Access Guarantee Committee, which had been established and co-chaired by the Minister of Health and the Minister of Science, Technology and Innovation would ensure that the supply of vaccines could be obtained immediately. We are also in final negotiations with Sinovac, CanSino and Gamaleya for Covid-19 vaccine supply, he said.
He said that the National Pharmaceutical Regulatory Agency (NPRA) of the Ministry of Health will continue to monitor the effectiveness and safety of vaccines once they are obtained and used.